Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Ho

Showing results (1241-1250 of 1,367) with videos related to

Pageof 137
Sort By:
The Journal of Clinical Investigation|September 24, 1999
HIV-1-specific immune responses in subjects who temporarily contain virus replication after discontinuation of highly active antiretroviral therapyG M Ortiz, D F Nixon, A Trkola, et al.
Cytotherapy|May 27, 2014
Standardization of Good Manufacturing Practice-compliant production of bone marrow-derived human mesenchymal stromal cells for immunotherapeutic applicationsPatrick Wuchter, Karen Bieback, Hubert Schrezenmeier, et al.
Immunohematology|May 7, 2021
An automated approach to determine antibody endpoint titers for COVID-19 by an enzyme-linked immunosorbent assayA D Ho, H Verkerke, J W Allen, et al.
Nature|July 5, 2022
Antibody evasion by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4 and BA.5Qian Wang, Yicheng Guo, Sho Iketani, et al.
Theranostics|May 23, 2017
Peptide vaccination in the presence of adjuvants in patients after hematopoietic stem cell transplantation with CD4+ T cell reconstitution elicits consistent CD8+ T cell responsesMichael Schmitt, Anita Schmitt, Markus Wiesneth, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 13, 2011
Eight cycles of escalated-dose BEACOPP compared with four cycles of escalated-dose BEACOPP followed by four cycles of baseline-dose BEACOPP with or without radiotherapy in patients with advanced-stage hodgkin's lymphoma: final analysis of the HD12 trial of the German Hodgkin Study GroupPeter Borchmann, Heinz Haverkamp, Volker Diehl, et al.
Nature|March 8, 2021
Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7Pengfei Wang, Manoj S Nair, Lihong Liu, et al.
Nature|March 3, 2022
Antibody evasion properties of SARS-CoV-2 Omicron sublineagesSho Iketani, Lihong Liu, Yicheng Guo, et al.
Biochemistry|May 10, 2006
Structure-guided design of peptide-based tryptase inhibitorsMary E McGrath, Paul A Sprengeler, Bernard Hirschbein, et al.
Biochimica Et Biophysica Acta. General Subjects|November 27, 2020
Structure-based, multi-targeted drug discovery approach to eicosanoid inhibition: Dual inhibitors of mPGES-1 and 5-lipoxygenase activating protein (FLAP)Joseph D Ho, Matthew R Lee, Charles T Rauch, et al.
Pageof 137

Showing results (1241-1250 of 1,367) with videos related to

Sort By:
Pageof 137
The Journal of Clinical Investigation|September 24, 1999
HIV-1-specific immune responses in subjects who temporarily contain virus replication after discontinuation of highly active antiretroviral therapyG M Ortiz, D F Nixon, A Trkola, et al.
Cytotherapy|May 27, 2014
Standardization of Good Manufacturing Practice-compliant production of bone marrow-derived human mesenchymal stromal cells for immunotherapeutic applicationsPatrick Wuchter, Karen Bieback, Hubert Schrezenmeier, et al.
Immunohematology|May 7, 2021
An automated approach to determine antibody endpoint titers for COVID-19 by an enzyme-linked immunosorbent assayA D Ho, H Verkerke, J W Allen, et al.
Nature|July 5, 2022
Antibody evasion by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4 and BA.5Qian Wang, Yicheng Guo, Sho Iketani, et al.
Theranostics|May 23, 2017
Peptide vaccination in the presence of adjuvants in patients after hematopoietic stem cell transplantation with CD4+ T cell reconstitution elicits consistent CD8+ T cell responsesMichael Schmitt, Anita Schmitt, Markus Wiesneth, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 13, 2011
Eight cycles of escalated-dose BEACOPP compared with four cycles of escalated-dose BEACOPP followed by four cycles of baseline-dose BEACOPP with or without radiotherapy in patients with advanced-stage hodgkin's lymphoma: final analysis of the HD12 trial of the German Hodgkin Study GroupPeter Borchmann, Heinz Haverkamp, Volker Diehl, et al.
Nature|March 8, 2021
Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7Pengfei Wang, Manoj S Nair, Lihong Liu, et al.
Nature|March 3, 2022
Antibody evasion properties of SARS-CoV-2 Omicron sublineagesSho Iketani, Lihong Liu, Yicheng Guo, et al.
Biochemistry|May 10, 2006
Structure-guided design of peptide-based tryptase inhibitorsMary E McGrath, Paul A Sprengeler, Bernard Hirschbein, et al.
Biochimica Et Biophysica Acta. General Subjects|November 27, 2020
Structure-based, multi-targeted drug discovery approach to eicosanoid inhibition: Dual inhibitors of mPGES-1 and 5-lipoxygenase activating protein (FLAP)Joseph D Ho, Matthew R Lee, Charles T Rauch, et al.
Pageof 137